Literature DB >> 11391773

Cryptic epitopes in N-terminally truncated prion protein are exposed in the full-length molecule: dependence of conformation on pH.

Y Matsunaga1, D Peretz, A Williamson, D Burton, I Mehlhorn, D Groth, F E Cohen, S B Prusiner, M A Baldwin.   

Abstract

Prion diseases are diseases of protein conformation. Structure-dependent antibodies have been sought to probe conformations of the prion protein (PrP) resulting from environmental changes, such as differences in pH. Despite the absence of such antibodies for full-length PrP, a recombinant Fab (D13) and a Fab derived from mAb 3F4 showed pH-dependent reactivity toward epitopes within the N-terminus of N-terminally truncated PrP(90-231). Refolding and maintaining this protein at pH > or =5.2 before immobilization on an ELISA plate inhibited reactivity relative to protein exposed to pH < or =4.7. The reactivity was not affected by pH changes after immobilization, showing retention of conformation after binding to the plate surface, although guanidine hydrochloride at 1.5-2 M was able to expose the cryptic epitopes after immobilization at pH > or =5.2. The alpha-helical CD spectrum of PrP(90-231) refolded at pH 5.5 was reduced somewhat by these pH changes, with a minor shift toward beta-sheet at pH 4 and then toward coil at pH 2. No covalent changes were caused by the pH differences. This pH dependence suggests titration of an acidic region that might inhibit the N-terminal epitopes. A similar pH dependence for a monoclonal antibody reactive to the central region identified an acidic region incorporating Glu152 as a significant participant. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11391773     DOI: 10.1002/prot.1077

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  29 in total

Review 1.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

2.  Influence of pH on the human prion protein: insights into the early steps of misfolding.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

3.  Characterization of monoclonal antibodies against altered (T103I) amidase from Pseudomonas aeruginosa.

Authors:  Sónia Martins; Amin Karmali; Jorge Andrade; Ana Custódio; Maria Luísa Serralheiro
Journal:  Mol Biotechnol       Date:  2005-07       Impact factor: 2.695

4.  Phosphorothioate oligonucleotides reduce PrP levels and prion infectivity in cultured cells.

Authors:  Marcela V Karpuj; Kurt Giles; Sagit Gelibter-Niv; Michael R Scott; Vishwanath R Lingappa; Francis C Szoka; David Peretz; Wilfred Denetclaw; Stanley B Prusiner
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

5.  Non-amyloid and amyloid prion protein deposits in prion-infected mice differ in blockage of interstitial brain fluid.

Authors:  A Rangel; B Race; J Striebel; B Chesebro
Journal:  Neuropathol Appl Neurobiol       Date:  2013-04       Impact factor: 8.090

6.  Phosphorylation of the amino terminus of maize sucrose synthase in relation to membrane association and enzyme activity.

Authors:  Shane C Hardin; Heike Winter; Steven C Huber
Journal:  Plant Physiol       Date:  2004-04       Impact factor: 8.340

7.  Scrapie protein degradation by cysteine proteases in CD11c+ dendritic cells and GT1-1 neuronal cells.

Authors:  Katarina M Luhr; Elin K Nordström; Peter Löw; Hans-Gustaf Ljunggren; Albert Taraboulos; Krister Kristensson
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Phosphorylated human tau associates with mouse prion protein amyloid in scrapie-infected mice but does not increase progression of clinical disease.

Authors:  Brent Race; Katie Phillips; Allison Kraus; Bruce Chesebro
Journal:  Prion       Date:  2016-07-03       Impact factor: 3.931

9.  Microglia Are Critical in Host Defense against Prion Disease.

Authors:  James A Carroll; Brent Race; Katie Williams; James Striebel; Bruce Chesebro
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

10.  Susceptibilities of nonhuman primates to chronic wasting disease.

Authors:  Brent Race; Kimberly D Meade-White; Michae W Miller; Kent D Barbian; Richard Rubenstein; Giuseppe LaFauci; Larisa Cervenakova; Cynthia Favara; Donald Gardner; Dan Long; Michael Parnell; James Striebel; Suzette A Priola; Anne Ward; Elizabeth S Williams; Richard Race; Bruce Chesebro
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.